Estimating scenarios for survival time in patients with metastatic melanoma receiving immunotherapy or targeted therapy

被引：0
|
作者：
Smith-Uffen, Megan [1 ]
Park, John [2 ]
Parsonson, Andrew [2 ]
Vasista, Anuradha [2 ]
机构：
[1] McMaster Univ, Hamilton, ON, Canada
[2] Nepean Blue Mountains Local Hlth Dist, Penrith, NSW, Australia
来源：
CANCER IMMUNOLOGY RESEARCH | 2022年 / 10卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A03
引用
收藏
页数：2
相关论文
共 50 条
  • [1] ESTIMATING SCENARIOS FOR SURVIVAL TIME IN PATIENTS WITH METASTATIC MELANOMA RECEIVING IMMUNOTHERAPY OR TARGETED THERAPY
    Smith-Uffen, Megan
    Park, John
    Parsonson, Andrew
    Vasista, Anuradha
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A452 - A452
  • [2] Estimating scenarios for survival time in patients with metastatic melanoma receiving immunotherapy or targeted therapy
    Smith-Uffen, M.
    Park, J.
    Parsonson, A.
    Vasista, A.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S1611 - S1611
  • [3] Estimating scenarios for survival time in patients with advanced melanoma receiving immunotherapy and targeted therapy
    Smith-Uffen, Megan
    Park, John
    Parsonson, Andrew
    Kiely, Belinda E.
    Vasista, Anuradha
    [J]. ONCOLOGIST, 2024,
  • [4] ESTIMATING SCENARIOS FOR SURVIVAL TIME IN PATIENTS WITH METASTATIC MELANOMA STARTING TARGETED THERAPIES AND IMMUNOTHERAPY
    Vasista, A.
    Stockler, M. R.
    Carlino, M. S.
    Kiely, B. E.
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 70 - 70
  • [5] Prognostic factors for response and survival in patients with metastatic melanoma receiving immunotherapy
    Keilholz, U
    Scheibenbogen, C
    Sommer, M
    Pritsch, M
    Geuke, AM
    [J]. MELANOMA RESEARCH, 1996, 6 (02) : 173 - 178
  • [6] Decreased survival in patients treated by chemotherapy after targeted therapy compared to immunotherapy in metastatic melanoma
    Mangin, Marie-Alix
    Boespflug, Amelie
    Maucort Boulch, Delphine
    Vacheron, Charles-Herve
    Carpentier, Isabelle
    Thomas, Luc
    Dalle, Stephane
    [J]. CANCER MEDICINE, 2021, 10 (10): : 3155 - 3164
  • [7] Use of extracranial radiation therapy in metastatic melanoma patients receiving immunotherapy
    Gabani, Prashant
    Robinson, Clifford G.
    Ansstas, George
    Johanns, Tanner M.
    Huang, Jiayi
    [J]. RADIOTHERAPY AND ONCOLOGY, 2018, 127 (02) : 310 - 317
  • [8] Oligoprogression After Immunotherapy and Targeted Therapy in Metastatic Melanoma
    Sobrevilla-Moreno, Nora
    Rivera-Sanchez, Daniel
    Garcia-Ortega, Dorian Y.
    Lopez-Macias, Diego
    Garcilazo-Reyes, Alexandra
    Alvarez-Avitia, Miguel A.
    [J]. ONCOLOGY-NEW YORK, 2021, 35 (09): : 562 - 566
  • [9] Targeted therapy and immunotherapy: Emerging biomarkers in metastatic melanoma
    LoRusso, Patricia M.
    Schalper, Kurt
    Sosman, Jeffrey
    [J]. PIGMENT CELL & MELANOMA RESEARCH, 2020, 33 (03) : 390 - 402
  • [10] ctDNA Monitoring of metastatic Melanoma patients receiving Immunotherapy
    Heidrich, I.
    Rautmann, C.
    Kott, J.
    Geidel, G.
    Ruenger, A.
    Streckenbach, A.
    Schneider, S. W.
    Pantel, K.
    Gebhardt, C.
    [J]. EXPERIMENTAL DERMATOLOGY, 2024, 33 (03)
12345